Comparing Non-Medicine Strategies for Improving Low Back Pain
Comparing Strategies to Improve Non-Pharmacologic Pain Relief for Adults With Back Pain (The ENCompaSS Trial)
2 other identifiers
interventional
530
1 country
1
Brief Summary
The goal of this clinical trial is to help veterans manage high-impact chronic pain (HICP) in the lower back. The trial will use a program, ENCompaSS (Education, Navigated Care, and Supported Self-Management) designed to reduce pain more than usual care alone. Researchers will assess a) the impact of ENCompaSS, b) identify which veterans benefit the most, and c) how this program can be delivered more broadly in other clinics and health systems. What Will Happen: Veterans in this clinical trial will be randomly placed into one of two groups. ENCompaSS group (intervention):
- Have at least three phone calls with a trained clinician over about 12 weeks
- Watch short online videos about managing pain
- Complete surveys before the study and again at 2, 4, 6, and 12 months Usual Stepped Care group:
- Will continue with regular care
- Complete the same surveys at the same time points
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 1, 2026
CompletedStudy Start
First participant enrolled
October 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2029
Study Completion
Last participant's last visit for all outcomes
July 31, 2029
July 28, 2026
June 1, 2026
2.8 years
June 25, 2026
July 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain interference with normal activities as assessed by PROMIS (Patient-Reported Outcomes Measurement Information System) Short Form 8a v1.0 score
The validated PROMIS Pain Interference instrument measures the self-reported consequences of pain across aspects of life including social, cognitive, emotional, physical, and recreational activities. The pain interference form asks the participant to rate a series of pain related questions on a scale of 1-5 within the past seven days with 1 representing a better outcome. Ratings are summed across the four questions and converted to a standardized T-score (mean 50, standard deviation 10) according to PROMIS Scoring tables. A higher score indicates greater pain interference.
From enrollment to 6 Months
Secondary Outcomes (7)
Average Ratings of Self-Reported Sleep Quality
Baseline to 6 Months
Average Ratings of Self-Reported Physical Function
Baseline to 6 Months
Average Self-Reported Pain Intensity Ratings
Baseline to 6 Months
Average Self-Reported Endorsement of Depression Symptoms
Baseline to 6 Months
Average Self-Reported Endorsement of Anxiety Symptoms
Baseline to 6 Months
- +2 more secondary outcomes
Study Arms (2)
ENCompaSS + VA Usual Stepped Care
ACTIVE COMPARATORThe ENCompaSS trial builds on pain navigation and management by integrating: * Structured pain education * Shared decision making using the OPTIONS decision aid * Facilitated referrals to preferred non pharmacologic treatments * Supported self-management (goal setting, problem solving, self-efficacy) * Asynchronous educational videos and optional SMS communication Veterans randomized to ENCompaSS receive at least three structured navigator-led phone sessions over 12 weeks, delivered by trained clinicians (e.g., nurses, physical therapists, health coaches) using existing VA resources.
VA Usual Stepped Care
NO INTERVENTIONParticipants randomized to VA usual stepped care alone will receive standard pain treatment available within the Veterans Health Administration (VHA) as directed by their treating provider and guided by the Stepped Care Model for Pain Management (SCM-PM). The SCM-PM, a tiered framework implemented system-wide through VHA Directive 2009-053, begins with the least intensive and most accessible treatments, progressing to more specialized and intensive interventions as needed. Key components include initial assessment and management in primary care, with referrals to specialists in pain medicine, physical medicine, rehabilitation, and behavioral health when primary care interventions are insufficient. VA usual stepped care participants will receive study materials to orient them to their treatment arm and provide assessment at multiple time points but will not receive any specific information or intervention related to LBP other than what normally would be provided.
Interventions
The ENCompaSS pain program was designed based on the Chronic Care Model (CCM), a widely used framework for organizing care for people with chronic diseases. In this model, the care provided for low back pain (LBP) meeting criteria for high-impact chronic pain (HICP), intentionally brings together the patient, provider, and system interventions necessary to accomplish the overall goal of improving pain outcomes and related co-morbidities. Our previous experiences with navigation in a previous study were only partially represented in the CCM. ENCompaSS employs a more comprehensive blend of CCM elements, incorporating important domains such Self-Management Support, which we posit will result in better pain interference outcomes.
Eligibility Criteria
You may qualify if:
- Be age 18 years old or older
- Have a VA outpatient clinic visit for low back pain within the previous 30 days
- Be enrolled in a participating primary care clinic
- Have high impact chronic pain per Graded Chronic Pain Scale (most days or every day on first 2 items)
- Valid telephone access
- Ability to provide informed consent
You may not qualify if:
- Are currently hospitalized or residing in a nursing home
- Have cognitive impairment or lack of decision-making capacity
- Have a serious mental illness (e.g., schizophrenia, bipolar disorder, recent psychiatric hospitalization, high risk suicide flag)
- Are unable to communicate by telephone or have no telephone access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Durham VA Medical Centercollaborator
- Indiana Universitycollaborator
- University of Arizonacollaborator
- Dallas VA Medical Centercollaborator
Study Sites (1)
Durham VA
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Hastings, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2026
First Posted
July 1, 2026
Study Start (Estimated)
October 1, 2026
Primary Completion (Estimated)
July 31, 2029
Study Completion (Estimated)
July 31, 2029
Last Updated
July 28, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The data and other resources referenced will be available one year after the date of publication for the primary analyses, which is in alignment with the VA Office of Research and Development.
- Access Criteria
- We plan on using a de-identified dataset and is not subject to HIPAA's minimum necessary standards and would not require a data use agreement. Typically, datasets will be provided in SAS transport files using CDISC standards via a website. Requesters will have to enter a valid email, phone number and address to request data. The data provided will be made available under certain requirements and approved on a case-by-case basis. Requirements include: * Data will be used for research purposes and not to identify subjects * Data must be secured using appropriate computer technology * Data must be destroyed or returned after any analysis are complete authors of any manuscript resulting from this data must acknowledge the source of the data * Analyses for the purpose of presentations, abstracts, and/or publications must be coordinated through the Publications Committee, to avoid overlap * Coauthors must be given a chance for review and approval of a draft manuscript prior to submission
Study data sets will be shared a timely manner with privacy and confidentiality protections to facilitate further research, reuse of data, and replication. Publications from this research will be made available to the public through the National Library of Medicine PubMed Central website. To enable broad resource sharing, the study statistician will create de-identified, publication-specific datasets including all variables presented in the publication. The PIs hold responsibility for ensuring that the individuals cannot be re-identified. No data or code that could lead to re-identification of individuals will be released. The analytical datasets and statistical code used will be retained in accordance with VA record retention policy. If successful outcomes justify broader dissemination, we will seek to do so by placing relevant materials into the public domain.